Cargando…

Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience

AIMS: Transplant services were imposed to the multiple challenges of insufficient facilities and resources during the COVID‐19 pandemic. Thus, each centre modified and altered its routine practice to maintain the service. We report our experience in Iran's single‐centre paediatric heart transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahdavi, Mohammad, Hejri, Golnar Mortaz, Shahzadi, Hossein, Dehaki, Maziar Gholampour, Houshmand, Golnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375075/
https://www.ncbi.nlm.nih.gov/pubmed/37343945
http://dx.doi.org/10.1002/ehf2.14443
_version_ 1785078950260637696
author Mahdavi, Mohammad
Hejri, Golnar Mortaz
Shahzadi, Hossein
Dehaki, Maziar Gholampour
Houshmand, Golnaz
author_facet Mahdavi, Mohammad
Hejri, Golnar Mortaz
Shahzadi, Hossein
Dehaki, Maziar Gholampour
Houshmand, Golnaz
author_sort Mahdavi, Mohammad
collection PubMed
description AIMS: Transplant services were imposed to the multiple challenges of insufficient facilities and resources during the COVID‐19 pandemic. Thus, each centre modified and altered its routine practice to maintain the service. We report our experience in Iran's single‐centre paediatric heart transplantation unit during the 2 year pandemic in transplant rate and early transplant outcomes. METHODS AND RESULTS: We retrospectively reviewed all paediatric heart transplants performed at our centre between 19 February 2020 and February 2022. We studied the number and percentage of paediatric transplanted patients who developed COVID‐19, in‐hospital outcome, 30 day survival and left ventricular function during the first month of the follow‐up visit. From February 2020 to February 2022, 59 transplants were performed compared with 62 patients from February 2018 to 2020. Compared with the year before the pandemic, the heart transplant rate was reduced by 34% in the first year of the pandemic; however, it bounced back in the second year with a 19% increase. The in‐hospital mortality rate during the 2 year pandemic was (11.8%). One death occurred related to COVID‐19 acute respiratory distress syndrome. The in‐hospital COVID‐19 infection rate was 11 patients (18%). In the 30 day follow‐up, the overall 30 day survival rate was 88%, and the 30 day rejection rate was 10%. The mean left ventricular ejection fraction was (53.6 ± 4.9), the mean left ventricular global longitudinal strain was −16.9 ± 3.3, and the mean right ventricular global longitudinal strain was −17.0 ± 3.8 with no significant difference between patients with in‐hospital COVID and other recipients (P = 0.1, P = 0.2 and P = 0.2). CONCLUSIONS: Throughout the pandemic, although we experienced a reduction in the transplant rate in the first year, with the increasing vaccination rate in health care and later in the general population, we continued to maintain our transplant rate by incorporating safety protocols and more resources.
format Online
Article
Text
id pubmed-10375075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-103750752023-07-29 Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience Mahdavi, Mohammad Hejri, Golnar Mortaz Shahzadi, Hossein Dehaki, Maziar Gholampour Houshmand, Golnaz ESC Heart Fail Original Articles AIMS: Transplant services were imposed to the multiple challenges of insufficient facilities and resources during the COVID‐19 pandemic. Thus, each centre modified and altered its routine practice to maintain the service. We report our experience in Iran's single‐centre paediatric heart transplantation unit during the 2 year pandemic in transplant rate and early transplant outcomes. METHODS AND RESULTS: We retrospectively reviewed all paediatric heart transplants performed at our centre between 19 February 2020 and February 2022. We studied the number and percentage of paediatric transplanted patients who developed COVID‐19, in‐hospital outcome, 30 day survival and left ventricular function during the first month of the follow‐up visit. From February 2020 to February 2022, 59 transplants were performed compared with 62 patients from February 2018 to 2020. Compared with the year before the pandemic, the heart transplant rate was reduced by 34% in the first year of the pandemic; however, it bounced back in the second year with a 19% increase. The in‐hospital mortality rate during the 2 year pandemic was (11.8%). One death occurred related to COVID‐19 acute respiratory distress syndrome. The in‐hospital COVID‐19 infection rate was 11 patients (18%). In the 30 day follow‐up, the overall 30 day survival rate was 88%, and the 30 day rejection rate was 10%. The mean left ventricular ejection fraction was (53.6 ± 4.9), the mean left ventricular global longitudinal strain was −16.9 ± 3.3, and the mean right ventricular global longitudinal strain was −17.0 ± 3.8 with no significant difference between patients with in‐hospital COVID and other recipients (P = 0.1, P = 0.2 and P = 0.2). CONCLUSIONS: Throughout the pandemic, although we experienced a reduction in the transplant rate in the first year, with the increasing vaccination rate in health care and later in the general population, we continued to maintain our transplant rate by incorporating safety protocols and more resources. John Wiley and Sons Inc. 2023-06-21 /pmc/articles/PMC10375075/ /pubmed/37343945 http://dx.doi.org/10.1002/ehf2.14443 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Mahdavi, Mohammad
Hejri, Golnar Mortaz
Shahzadi, Hossein
Dehaki, Maziar Gholampour
Houshmand, Golnaz
Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title_full Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title_fullStr Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title_full_unstemmed Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title_short Paediatric heart transplantation during the COVID‐19 pandemic in Iran: single‐centre experience
title_sort paediatric heart transplantation during the covid‐19 pandemic in iran: single‐centre experience
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375075/
https://www.ncbi.nlm.nih.gov/pubmed/37343945
http://dx.doi.org/10.1002/ehf2.14443
work_keys_str_mv AT mahdavimohammad paediatrichearttransplantationduringthecovid19pandemiciniransinglecentreexperience
AT hejrigolnarmortaz paediatrichearttransplantationduringthecovid19pandemiciniransinglecentreexperience
AT shahzadihossein paediatrichearttransplantationduringthecovid19pandemiciniransinglecentreexperience
AT dehakimaziargholampour paediatrichearttransplantationduringthecovid19pandemiciniransinglecentreexperience
AT houshmandgolnaz paediatrichearttransplantationduringthecovid19pandemiciniransinglecentreexperience